Document:

Exhibit
10.1

 

SECURITIES
PURCHASE AGREEMENT

 

THIS
SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 26th day of June, 2020,
by and among Hancore Pty Ltd, a shareholder of CBD Imports Pty Ltd (hereinafter referred to as the “Seller”) and Kibush
Capital Corp., a Nevada corporation (hereinafter referred to as the “Buyer”), as follows:

 

Premises

 

A.
The Buyer and Seller are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under
the Securities Act of 1933, as amended (the “1933 Act”)

 

B.
Seller owns a fifty one percent (51%) interest in CBD Imports Pty Ltd., an Australian proprietary company (hereinafter referred
to as the “CBD”), including 5,100 shares of CBD’s common stock (“CBD Stock”).

 

C.
Buyer is a public company in the U.S. traded on OTCPink. Buyer desires to use its common stock par value $0.001 (“Kibush
Stock”) as consideration for the purchase of CBD Stock, and Seller desires to receive Kibush Stock in exchange for its CBD
Stock, upon the terms and conditions set forth in this Agreement.

 

Agreement

 

BASED,
upon the foregoing premises, which are incorporated herein by this reference, and for and in consideration of the mutual promises
and covenants hereinafter set forth, and other good and valuable consideration the receipt and adequacy of which are hereby acknowledged,
it is agreed as follows:

 

ARTICLE
I

PURCHASE
OF COMMON STOCK

 

1.01
Purchase and Sale of Common Stock. Buyer agrees to purchase from the Seller and the Seller agrees to sell to Buyer five
thousand one hundred (5,100) shares of CBD Stock. As such, Buyer will issue 5,000,000 Preference A Stock of Kibush Stock to the
Seller in exchange for 5,100 shares of CBD Stock. 

 

1.02
Closing.

 

	 	a)	The
    purchase of Common Stock and sale of Preference shares shall take place at 7 Sarah Crescent, Templestowe VIC 3106 at such
    date and time as shall be determined by the Buyer and the Seller but in no event later than June 26, 2020.
	 	 	 
	 	b)	At
    the Closing:

 

	 	i)	The
    Seller shall deliver to the Buyer a certificate (or certificates) for 5,100 shares of CBD Stock.

 

    	-1-

     

    

 

	 	ii)	The
    Buyer shall deliver to Seller a certificate (or certificates) for 5,000,000 Preference A Kibush Stock.
	 	 	 
	 	iii)	At
    any time after the Closing, the parties shall duly execute, acknowledge and deliver all such further assignments, conveyances,
    instruments and documents, and shall take such other action consistent with the terms of this Agreement to carry out the transactions
    contemplated by this Agreement. 
	 	 	 
	 	iv)	All
    representations, covenants and warranties of the Buyer and Buyer contained in this Agreement shall be true and correct on
    and as of the closing date with the same effect as though the same had been made on and as of such date.

 

ARTICLE
II

REPRESENTATIONS,
COVENANTS, AND WARRANTIES

OF
THE BUYER 

 

As
an inducement to, and to obtain the reliance of the Seller in connection with the issuance of Kibush Stock, Buyer represents and
warrants as follows:

 

2.01
Private Offering. The offer, offer for sale, and sale of the shares of Kibush Stock have not been and will not be registered
with the Securities and Exchange Commission (the “Commission”). The shares of Kibush Stock shall be offered for sale
and sold pursuant to the exemptions from the registration requirements of Section 5 of the United States Securities Act of 1933,
as amended, and as such, will be deemed “restricted securities” limiting the shares ability to be resold. 

 

2.02
Approval of Agreement. Buyer has full corporate power, authority, and legal right and has taken, or will take, all action
required by law, its articles of incorporation, bylaws, and otherwise to execute and deliver this Agreement and to consummate
the transactions herein contemplated including the issuance of the shares of the Kibush Stock. The board of directors of the Buyer
has authorized and approved the execution, delivery, and performance of this Agreement and the transactions contemplated hereby
including the issuance of the Kibush Stock.

 

2.03
Legal Right. The performance of this Agreement and the consummation of the transactions herein contemplated will not result
in a material breach or violation of any of the terms and provisions of, or constitute a default under, any statute (except federal
and state securities laws, compliance with which is elsewhere provided for in particular detail), indenture, mortgage or other
agreement or instrument to which the Buyer is a party or by which it is bound by any order, rule or regulation directed to such
party or its affiliates by any court or governmental agency or body having jurisdiction over them; and no other consent, approval,
authorization or action is required for the consummation of the transactions herein contemplated other than such as have been
obtained.

 

2.04
Validly Issued. The Kibush Stock, when issued, will be duly authorized, validly issued, and non-assessable.

 

    	-2-

     

    

 

2.05
Organization. The Buyer has been duly organized and is now, and always during the period of the offer and sale will be,
a validly existing corporation under the laws of the state of Nevada lawfully qualified to conduct the business for which it was
organized and which it proposes to conduct. 

 

2.06
Capitalization. The Buyer has an authorized capitalization of 2,000,000,000 shares of common stock, $0.001 par value and
50,000,000 shares of preferred stock, par value $0.001 per share. The Buyer currently has 443,354,541 shares of common stock issued
and outstanding and 45,000,000 shares of preferred stock issued and outstanding. 

 

2.07
Title and Related Matters. Except as disclosed, or disclosed in the most recent balance sheet of the Buyer and the notes
thereto, the Buyer has good and marketable title to all of its properties, inventory, interests in properties, and assets, which
are reflected in the most recent balance sheet of the Buyer or acquired after that date (except properties, interests in properties,
and assets sold or otherwise disposed of since such date in the ordinary course of business), free and clear of all mortgages,
liens, pledges, charges, or encumbrances, except (i) statutory liens or claims not yet delinquent; and (ii) such imperfections
of title and easements as do not, and will not, materially detract from, or interfere with, the present or proposed use of the
properties subject thereto or affected thereby or otherwise materially impair present business operations on such properties.

 

2.09
Litigation and Proceedings. There are no actions, suits, or proceedings pending or, to the knowledge of the Buyer, threatened
by or against the Buyer or affecting the Buyer, at law or in equity, before any court or other governmental agency or instrumentality,
domestic or foreign, or before any arbitrator of any kind. The Buyer does not have any knowledge of any default on its part with
respect to any judgment, order, writ, injunction, decree, award, rule, or regulation of any court, arbitrator, or governmental
agency or instrumentality.

 

2.10
Material Contract Defaults. The Buyer is not in default in any material respect under the terms of any outstanding contract,
agreement, lease, or other commitment which is material to the business, operations, properties, assets, or condition of the Buyer,
and there is no event of default or other event which, with notice or lapse of time or both, would constitute a default in any
material respect under any such contract, agreement, lease, or other commitment in respect of which the Buyer has not taken adequate
steps to prevent such a default from occurring.

 

2.11
Absence of Certain Changes of Events. Except as set forth in this Agreement since the date of Buyer’s most recent
balance sheet: 

 

(a)
Except as disclosed on a separate schedule, there has not been (i) any material adverse change in the business, operations, properties,
level of inventory, assets, or condition of the Buyer or (ii) any damage, destruction, or loss to the Buyer (whether or not covered
by insurance) materially and adversely affecting the business, operations, properties, assets, or conditions of the Buyer.

 

(b)
The Buyer has not (i) amended its articles of incorporation or bylaws; (ii) declared or made, or agreed to declare or make, any
payment of dividends or distributions of any assets of any kind whatsoever to stockholders or purchased or redeemed, or agreed
to purchase or redeem, any of its capital stock; (iii) waived any rights of value which in the aggregate are extraordinary or
material considering the business of the Buyer; (iv) made any material change in its method of management, operation, or accounting;
(v) entered into any other material transactions outside normal business operations;

 

    	-3-

     

    

 

(c)
Except as disclosed on a separate schedule, the Buyer has not (i) granted or agreed to grant any options, warrants, or other rights
for its stocks, bonds, or other corporate securities calling for the issuance thereof; (ii) borrowed or agreed to borrow any funds
or incurred, or become subject to, any material obligation or liability (absolute or contingent) except liabilities incurred in
the ordinary course of business; (iii) paid any material obligation or liability (absolute or contingent) other than current liabilities
reflected in or shown on the most recent balance sheet of the Buyer and current liabilities incurred since that date in the ordinary
course of business; (iv) sold or transferred, or agreed to sell or transfer, any of its assets, properties, or rights (except
assets, properties, or rights not used or useful in its business which, in the aggregate have a value of less than $25,000 or
canceled, or agreed to cancel, any debts or claims (except debts and claims which in the aggregate are of a value of less than
$25,000); (v) made or permitted any amendment or termination of any contract, agreement, or license to which it is a party if
such amendment or termination is material, considering the business of the Buyer; or (vi) issued, delivered, or agreed to issue
or deliver any stock, bonds, or other corporate securities including debentures (whether authorized and unissued or held as treasury
stock); and

 

(d)
To the best knowledge of the Buyer, it has not become subject to any law or regulation which materially and adversely affects,
or in the future may adversely affect, the business, operations, properties, assets, or condition of the Buyer.

 

ARTICLE
III

REPRESENTATIONS,
COVENANTS, AND WARRANTIES

OF
THE SELLER

 

As
an inducement to, and to obtain the reliance of the Buyer in connection with its purchase of the shares of CBD Stock, Seller represents
and warrants as follows:

 

3.01
Private Offering. The offer, offer for sale, and sale of the shares of CBD Stock have not been and will not be registered
with the Securities and Exchange Commission (the “Commission”). The shares of CBD Stock shall be offered for sale
and sold pursuant to the exemptions from the registration requirements of Section 5 of the United States Securities Act of 1933,
as amended, (or such similar laws of Australia) and as such, will be deemed “restricted securities” limiting the shares
ability to be resold. 

 

3.02
Approval of Agreement. Seller has full corporate power, authority, and legal right and has taken, or will take, all action
required by law, its articles of incorporation, bylaws, and otherwise to execute and deliver this Agreement and to consummate
the transactions herein contemplated including the sale and transfer of the shares of the CBD Stock. The execution, delivery,
and performance of this Agreement and the transactions contemplated hereby, have been duly authorized by Seller.

 

3.03
Legal Right. The performance of this Agreement and the consummation of the transactions herein contemplated will not result
in a material breach or violation of any of the terms and provisions of, or constitute a default under, any statute (except federal
and state securities laws, compliance with which is elsewhere provided for in particular detail), indenture, mortgage or other
agreement or instrument to which the Seller is a party or by which it is bound by any order, rule or regulation directed to such
party or its affiliates by any court or governmental agency or body having jurisdiction over them; and no other consent, approval,
authorization or action is required for the consummation of the transactions herein contemplated other than such as have been
obtained.

 

    	-4-

     

    

 

3.04
Organization. The Seller has been duly organized and is now, and always during the period of the offer and sale will be,
a validly existing limited company under the laws of Australia, lawfully qualified to conduct the business for which it was organized
and which it proposes to conduct. 

 

3.05
Securities Representations. Seller understands and agrees that the consummation of this Agreement including the issuance
of shares of Kibush Stock as contemplated hereby, constitutes the offer and sale of securities under the Securities Act. Seller
agrees that such transactions shall be consummated in reliance on exemptions from the registration and prospectus delivery requirements
of such statutes which depend, among other items, on the circumstances under which such securities are acquired. In order to provide
documentation for reliance upon exemptions from the registration and prospectus delivery requirements for such transactions, Seller
agrees that it will sign appropriate representations and warranties related to its suitability to invest in the Buyer, including
an investment letter and suitability questionnaire which are contained in the “suitability letter” attached hereto
as Exhibit “A.” Seller understands that the shares of Kibush Stock have not been registered under the Securities Act
and must be held indefinitely without any transfer, sale, or other disposition unless such shares are subsequently registered
under the Securities Act or registration is not required under the Securities Act in reliance on an available exemption. The shares
of Kibush Stock to be acquired by the Seller under the terms of this Agreement will be acquired for the Seller’s own account,
for investment, and not with the present intention of resale or distribution of all or any part of the securities. Seller agrees
that it will refrain from transferring or otherwise disposing of any of the shares, or any interest therein, in such manner as
to violate the Securities Act or any applicable state securities law regulating the disposition thereof. Seller is an “accredited
investor” within the meaning of Regulation D promulgated under the Securities Act and has adequate means for providing for
its current needs and possible personal contingencies and has no need now and anticipates no need in the foreseeable future to
sell the shares of Kibush Stock which Seller is purchasing hereby. Seller understands that the shares of Kibush Stock being sold
pursuant to this Agreement are being offered and sold in reliance on specific exemptions from the registration requirements of
Federal and state securities laws and that the Buyer is relying upon the truth and accuracy of Seller’s representations,
warranties, agreements, and understandings set forth herein to determine Seller’s suitability to acquire the shares of Kibush
Stock.

 

3.06
Disclosure Information. Seller has received all the information Seller considers necessary or appropriate for deciding
whether or not to purchase the shares of Kibush Stock. Seller further represents that it has had an opportunity to ask questions
and receive answers from the Buyer regarding the terms and conditions of the offering of the shares of Kibush Stock. The foregoing,
however, does not limit or modify the representations and warranties of the Buyer in Article 2 of this Agreement or the right
of Seller to rely thereon.

 

3.07
Investment Experience. Seller is an investor in securities of companies in the development stage and acknowledges that
it is able to fend for itself, can bear the economic risk of its investment and has such knowledge and experience in financial
or business matters that it is capable of evaluating the merits and risks of the investment in the shares of Kibush Stock.

 

3.08
Acknowledgment. Seller acknowledges that an investment in the shares of Kibush Stock involves substantial risk.

 

    	-5-

     

    

 

3.09
Knowledge of Buyer. Seller is aware, through its own extensive due diligence of all material information respecting the
past, present and proposed business operations of the Buyer, including, but not limited to, its technology, its management, its
financial position, or otherwise; and that the purchase price being paid for the Kibush Stock bears no relationship to assets,
book value or other established criteria of value. Seller has conducted its own investigation of the risks and merits of an investment
in the Buyer, and to the extent desired, including, but not limited to a review of the Buyer’s books and records, financial
and Seller has had the opportunity to discuss this documentation with the directors and executive officers of the Buyer; to ask
questions of these directors and executive officers; and that to the extent requested, all such questions have been answered to
its satisfaction.

 

3.10
Informed Decision. The Seller has had an opportunity to consult with its independent legal, tax and financial advisors,
and together with such advisors, has evaluated the transactions contemplated in this Agreement and has independently determined
to agree to the terms and conditions of this Agreement. No representation is being or has been made by the Seller, the Buyer or
either of their respective advisors to the Seller regarding the tax, financial, legal or other effects to the Seller or its stockholders
of the transactions contemplated in this Agreement. The Seller is familiar with and understands the business and financial condition,
operations and prospects of the Buyer and Seller and is sufficiently informed and sophisticated enough to make a decision regarding
the transactions contemplated by this Agreement.

 

3.11
Purchasing Entirely for Own Account. The shares to be acquired by the Seller will be acquired for investment for the Seller’s
own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and the Seller
and its stockholders have no present intention of selling, granting any participation in, or otherwise distributing the same.
Neither the Seller nor its stockholders presently have any contract, undertaking, agreement or arrangement with any person to
sell, transfer or grant participations to such person or to any third person, with respect to any of the Buyer shares of Kibush
Stock.

 

3.12
Disclosure of Information. The Seller has had an opportunity to discuss the Buyer’s business, management, financial
affairs and the terms and conditions of the sale of the shares of Kibush Stock with the Buyer’s management and has had an
opportunity to review the Buyer’s records. The Seller is aware, through its due diligence review of the Buyer that the Purchase
Price for the shares of Kibush Stock bear no relationship to assets, book value or other established criteria of determining value.
The Seller will further inform the Buyer of any discrepancies, error or disagreement between any representation, warranty, covenant
or schedule of the Buyer or Seller based on Seller’s review of the due diligence information and discussions with the Buyer
or its management or has otherwise come to the Seller’s attention and will provide such notice to the Buyer as soon as practicable
after such discovery.

 

3.13
Accredited Investor. The Seller is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the
Securities Act.

 

3.14
Patriot Act.

 

(a)
The Seller is not in violation of any legal requirements relating to terrorism or money laundering (“Anti-Terrorism Laws”),
including Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001 (the “Executive Order”),
and the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001,
Public Law 107-56 (the “Patriot Act”).

 

    	-6-

     

    

 

(b)
The Seller, nor, to the Seller’s Knowledge, any affiliate, stockholder or broker or other agent of the Seller acting or
benefiting in any capacity in connection with this Agreement is any of the following:

 

(i)
a person that is listed in the annex to, or is otherwise subject to the provisions of, the Executive Order;

 

(ii)
a person owned or controlled by, or acting for or on behalf of, any person that is listed in the annex to, or is otherwise subject
to the provisions of, the Executive Order;

 

(iii)
a person with which any party is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law;

 

(iv)
a person that commits, threatens or conspires to commit or supports “terrorism” as defined in the Executive Order;
or

 

(v)
a person that is named as a “specially designated national and blocked person” on the most current list published
by OFAC at its official website or any replacement website or other replacement official publication of such list.

 

(c)
The Seller, nor, to the Seller’s Knowledge, any affiliate or stockholders or broker or other agent of the Seller acting
in any capacity in connection with this Agreement (i) conducts any business or engages in making or receiving any contribution
of funds, goods or services to or for the benefit of any person described in Section 3.14(b), (ii) deals in, or otherwise engages
in any transaction relating to, any property or interests in property blocked pursuant to the Executive Order, or (iii) engages
in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to
violate, any of the prohibitions set forth in any Anti-Terrorism Law.

 

3.15
Investment Experience. Seller is an investors in securities of companies with size and structure similar to the Buyer’s
and acknowledges that Seller is able to fend for itself, can bear the economic risk of its investment and has such knowledge and
experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the shares
of Kibush Stock and in the proposed ongoing operations. Further, Seller acknowledges that the future success of the Buyer will
depend on Seller’s management and not on the current management of the Buyer.

 

ARTICLE
IV

SPECIAL
COVENANTS

 

4.01
Business Activities of CBD.

 

(a)
From and after the date of this Agreement until the closing date and except as set forth herein or as permitted or contemplated
by this Agreement, Seller warrants that CBD will:

 

(i)
Carry on its business in substantially the same manner as it has heretofore.

 

(ii)
Maintain in full force and effect insurance comparable in amount and in scope of coverage to that now maintained by it;

 

(iii)
Perform in all material respects all of its obligations under material contracts, leases, and instruments relating to or affecting
its assets, properties, and business;

 

    	-7-

     

    

 

(iv)
Use its best efforts to maintain and preserve it business organization intact, to retain its key employees, and to maintain its
relationships with its material suppliers and customers;

 

(v)
Except to the extent that noncompliance is not material or adverse to the respective party, duly and timely file for all taxable
periods ending on or prior to the closing date all federal, state, county, and local tax returns required to be filed by or on
behalf of such entity or for which such entity may be held responsible and shall pay, or cause to pay, all taxes required to be
shown as due and payable on such returns, as well as all installments of tax due and payable during the period commencing on the
date of this Agreement and ending on the closing date; and

 

(vi)
Fully comply with and perform in all material respects all obligations and duties imposed on it by all federal and state laws
and all rules, regulations, and orders imposed by federal or state governmental authorities.

 

(b)
From and after the date of this Agreement and except as provided herein until the closing date, Seller warrants that CBD will
not:

 

(i)
Make any change in its articles of incorporation or bylaws;

 

(ii)
Enter into or amend any material contract, agreement, or other instrument, except in the ordinary course of business; and

 

(iii)
Enter into any agreement for the sale of the CBD ‘s securities without the prior approval of the other party.

 

4.02
Business Activities of Buyer.

 

(a)
From and after the date of this Agreement until the closing date and except as set forth herein or as permitted or contemplated
by this Agreement, Buyer will:

 

(i)
Carry on its business in substantially the same manner as it has heretofore;

 

(ii)
Maintain in full force and effect insurance comparable in amount and in scope of coverage to that now maintained by it;

 

(iii)
Perform in all material respects all of its obligations under material contracts, leases, and instruments relating to or affecting
its assets, properties, and business;

 

(iv)
Use its best efforts to maintain and preserve it business organization intact, to retain its key employees, and to maintain its
relationships with its material suppliers and customers;

 

(v)
Except to the extent that noncompliance is not material or adverse to the respective party, duly and timely file for all taxable
periods ending on or prior to the closing date all federal, state, county, and local tax returns required to be filed by or on
behalf of such entity or for which such entity may be held responsible and shall pay, or cause to pay, all taxes required to be
shown as due and payable on such returns, as well as all installments of tax due and payable during the period commencing on the
date of this Agreement and ending on the closing date; and

 

    	-8-

     

    

 

(vi)
Fully comply with and perform in all material respects all obligations and duties imposed on it by all federal and state laws
and all rules, regulations, and orders imposed by federal or state governmental authorities.

 

(b)
From and after the date of this Agreement and except as provided herein until the closing date, Buyer will not:

 

(i)
Make any change in its articles of incorporation or bylaws;

 

(ii)
Enter into or amend any material contract, agreement, or other instrument, except in the ordinary course of business; and

 

(iii)
Enter into any agreement for the sale of the Buyer’s securities without the prior approval of the other party.

 

4.03
Access to Books and Records of CBD. Until the closing date, the Seller will afford to Buyer and its authorized representatives
full access to the properties, books, and records of the CBD in order that Buyer may have full opportunity to make such reasonable
investigation as it shall desire to make of the affairs of CBD and will furnish the Buyer with such additional financial and other
information as to the business and properties of the CBD as Buyer shall from time to time reasonably request. 

 

4.04
Access to Books and Records of Buyer. Until the closing date, the Buyer will afford to Seller and its authorized representatives
full access to the properties, books, and records of the Buyer in order that Seller may have full opportunity to make such reasonable
investigation as it shall desire to make of the affairs of Buyer and will furnish the Seller with such additional financial and
other information as to the business and properties of the Buyer as Seller shall from time to time reasonably request.

 

4.05
Purchase and Sale of Stock. The Buyer and Seller agree and understand that the consummation of this Agreement including
the purchase, sale and exchange of the shares of CBD Stock and Kibush Stock as contemplated hereby, constitutes the offer and
sale of securities under the Securities Act and applicable state statutes. The Buyer and Seller agree such transactions shall
be consummated in reliance on exemptions from the registration and prospectus delivery requirements of such statutes which depend,
among other items, on the circumstances under which such securities are acquired.

 

(a)
In order to provide documentation for reliance upon exemptions from the registration and prospectus delivery requirements for
such transactions, the signing of this Agreement and the delivery of appropriate separate representations, including the “suitability
letter” attached hereto as Exhibit “A” shall constitute the parties acceptance of, and concurrence in, the following
representations and warranties:

 

(i)
Seller acknowledges that neither the SEC nor the securities commission of any state or other federal agency has made any determination
as to the merits of acquiring the shares of Common Stock, and that this transaction involves certain risks.

 

    	-9-

     

    

 

(ii)
Seller has received and read the Agreement and understand the risks related to the consummation of the transactions herein contemplated.

 

(iii)
Seller has such knowledge and experience in business and financial matters that it can evaluate each business.

 

(iv)
Seller has been provided with copies of all materials and information requested by Buyer or their representatives, including any
information requested to verify any information furnished (to the extent such information is available or can be obtained without
unreasonable effort or expense), and the parties have been provided the opportunity for direct communication regarding the transactions
contemplated hereby.

 

(v)
All information which Seller has provided to the Buyer or their representatives concerning their suitability and intent to hold
shares in Kibush Stock following the transactions contemplated hereby is complete, accurate, and correct.

 

(vi)
Seller has not offered or sold any securities of the Buyer or interest in this Agreement and has no present intention of dividing
the shares of Kibush Stock to be received or the rights under this Agreement with others or of reselling or otherwise disposing
of any portion of such stock or rights, either currently or after the passage of a fixed or determinable period of time or on
the occurrence or nonoccurrence of any predetermined event or circumstance.

 

(vii)
Seller understand that the shares of Kibush Stock have not been registered, but are being acquired by reason of a specific exemption
under the Securities Act as well as under certain state statutes for transactions not involving any public offering and that any
disposition of the subject shares of Kibush Stock may, under certain circumstances, be inconsistent with this exemption and may
make Seller an “underwriter,” within the meaning of the Securities Act. It is understood that the definition of “underwriter”
focuses upon the concept of “distribution” and that any subsequent disposition of the subject shares of Kibush Stock
can only be effected in transactions which are not considered distributions. Generally, the term “distribution” is
considered synonymous with “public offering” or any other offer or sale involving general solicitation or general
advertising. Under present law, in determining whether a distribution occurs when securities are sold into the public market,
under certain circumstances one must consider the availability of public information regarding the issuer, a holding period for
the securities sufficient to assure that the persons desiring to sell the securities without registration first bear the economic
risk of their investment, and a limitation on the number of securities which the stockholder is permitted to sell and on the manner
of sale, thereby reducing the potential impact of the sale on the trading markets. These criteria are set forth specifically in
rule 144 promulgated under the Securities Act.

 

    	-10-

     

    

 

(viii)
Seller acknowledges that the shares of Kibush Stock must be held and may not be sold, transferred, or otherwise disposed of for
value unless they are subsequently registered under the Securities Act or an exemption from such registration is available. The
Buyer is not under any obligation to register the shares of Kibush Stock under the Securities Act, except as set forth in this
Agreement. The Buyer is not under any obligation to make rule 144 available, except as may be expressly agreed to by it in writing
in this Agreement, and in the event rule 144 is not available, or some other disclosure exemption may be required before Seller
can sell, transfer, or otherwise dispose of such shares of Kibush Stock without registration under the Securities Act. The Buyer’s
registrar and transfer agent will maintain a stop transfer order against the registration or transfer of the shares of Kibush
Stock, and the certificates representing the shares of Kibush Stock will bear a legend in substantially the following form so
restricting the sale of such securities:

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”) AND ARE “RESTRICTED SECURITIES” WITHIN THE MEANING OF RULE 144 PROMULGATED UNDER THE SECURITIES ACT. THE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD OR TRANSFERRED WITHOUT COMPLYING WITH RULE 144 IN THE ABSENCE
OF AN EFFECTIVE REGISTRATION OR OTHER COMPLIANCE UNDER THE SECURITIES ACT.

 

(ix)
The Buyer may refuse to register further transfers or resales of the shares of Kibush Stock in the absence of compliance with
rule 144 unless the Seller furnish the Buyer with a “no-action” or interpretive letter from the SEC or an opinion
of counsel reasonably acceptable to the Buyer stating that the transfer is proper. Further, unless such letter or opinion states
that the shares of Kibush Stock are free of any restrictions under the Securities Act, the Buyer may refuse to transfer the securities
to any transferee who does not furnish in writing to the Buyer the same representations and agree to the same conditions with
respect to such shares of Kibush Stock as set forth herein. The Buyer may also refuse to transfer the shares of Kibush Stock if
any circumstances are present reasonably indicating that the transferee’s representations are not accurate.

 

(b)
In connection with the transaction contemplated by this Agreement, the Buyer and Seller shall each file, with the assistance of
the other and their respective legal counsel, such notices, applications, reports, or other instruments as may be deemed by them
to be necessary or appropriate in an effort to document reliance on such exemptions, and the appropriate regulatory authority
in the states where Buyer reside unless an exemption requiring no filing is available in such jurisdictions, all to the extent
and in the manner as may be deemed by such parties to be appropriate.

 

(c)
In order to more fully document reliance on the exemptions as provided herein, the Buyer and Seller shall execute and deliver
to the other, at or prior to the closing, such further letters of representation, acknowledgment, suitability, or the like as
the Buyer or Seller (or their respective counsel) may reasonably request in connection with reliance on exemptions from registration
under such securities laws including but not limited to an investment letter.

 

(d)
The Buyer and Seller acknowledge that the basis for relying on exemptions from registration or qualifications are factual, depending
on the conduct of the various parties, and that no legal opinion or other assurance will be required or given to the effect that
the transactions contemplated hereby are in fact exempt from registration or qualification.

 

    	-11-

     

    

 

4.06
Compliance with Rule 144.

 

(a)
The Buyer will use its best efforts to at all times satisfy the current public information requirements of rule 144 promulgated
under the Securities Act so that its shareholders can sell restricted securities that have been held for one year or more or such
other restricted period as required by rule 144 as it is from time to time amended. This covenant shall survive the closing of
this Agreement.

 

(b)
Upon being informed in writing by any person holding restricted stock sold pursuant to this Agreement that such person intends
to sell any shares under rule 144 promulgated under the Securities Act (including any rule adopted in substitution or replacement
thereof), the Buyer will certify in writing to such person that it is compliance with rule 144 current public information requirement
to enable such person to sell such person’s restricted stock under rule 144, as may be applicable under the circumstances.

 

(c)
If any certificate representing any such restricted stock is presented to the Buyer’s transfer agent for registration or
transfer in connection with any sales theretofore made under rule 144, provided such certificate is duly endorsed for transfer
by the appropriate person(s) or accompanied by a separate stock power duly executed by the appropriate person(s) in each case
with reasonable assurances that such endorsements are genuine and effective, and is accompanied by an opinion of counsel satisfactory
to the Buyer and its counsel that such transfer has complied with the requirements of rule 144, as the case may be, the Buyer
will promptly instruct its transfer agent to register such transfer and to issue one or more new certificates representing such
shares to the transferee and, if appropriate under the provisions of rule 144, as the case may be, free of any stop transfer order
or restrictive legend.

 

4.07
Public Statements. Subject to their respective legal obligations (including requirements of stock exchanges and other similar
regulatory bodies), the Seller and Buyer shall consult with one another, and use reasonable best efforts to agree upon the text
of any press release, before issuing any such press release or otherwise making public statements with respect to the transactions
and in making any filing with any federal or state governmental or regulatory agency or with any securities exchange with respect
thereto.

 

4.08
No Representation Regarding Tax Treatment. No representation or warranty is being made by any party to any other regarding
the treatment of this transaction for federal or state income taxation. Each party has relied exclusively on its own legal, accounting,
and other tax adviser regarding the treatment of this transaction for federal and state income taxes and on no representation,
warranty, or assurance from any other party or such other party’s legal, accounting, or other adviser.

 

4.09
Expenses of Sale. The Buyer will pay all expenses incident to the performance of its obligations hereunder, including but
not limited to the fees and expenses of its counsel and accountants, and the cost of qualifying the offer and sale of the shares
of Kibush Stock in various jurisdictions or obtaining an exemption therefrom. The Seller shall be responsible for all of its expenses
including the cost associated with transfer of the CBD Shares and its attorney’s fees.

 

    	-12-

     

    

 

ARTICLE
V

MISCELLANEOUS

 

5.01
Attorney’s Fees. In the event that any party institutes any action or suit to enforce this Agreement or to secure
relief from any default hereunder or breach hereof, the breaching party or parties shall reimburse the nonbreaching party or parties
for all costs, including reasonable attorneys’ fees, incurred in connection therewith and in enforcing or collecting any
judgment rendered therein.

 

5.02
Entire Agreement. This Agreement represents the entire agreement between the parties relating to the subject matter hereof.
All previous agreements between the parties, whether written or oral, have been merged into this Agreement. This Agreement alone
fully and completely expresses the agreement of the parties relating to the subject matter hereof. There are no other courses
of dealing, understandings, agreements, representations, or warranties, written or oral, except as set forth herein.

 

5.03
Survival; Termination. The representations, warranties, and covenants of the respective parties shall survive the closing
and the consummation of the transactions herein contemplated for a period of six months from the closing, unless otherwise provided
herein.

 

5.04
Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all
of which taken together shall be but a single instrument.

 

5.05
Amendment or Waiver. Every right and remedy provided herein shall be cumulative with every other right and remedy, whether
conferred herein, at law, or in equity, and such remedies may be enforced concurrently, and no waiver by any party of the performance
of any obligation by the other shall be construed as a waiver of the same or any other default then, theretofore, or thereafter
occurring or existing. At any time prior to the closing, this Agreement may be amended by a writing signed by all parties hereto,
with respect to any of the terms contained herein, and any term or condition of this Agreement may be waived or the time for performance
thereof may be extended by a writing signed by the party or parties for whose benefit the provision is intended.

 

5.06
Binding Effect. This Agreement shall inure to the benefit of and be binding upon the Buyer and Seller and their successors.
Nothing expressed in this Agreement is intended to give any person other than the persons mentioned in the preceding sentence
any legal or equitable right, remedy or claim under this Agreement. 

 

5.07
Severability. Every provision of this Agreement is intended to be severable. If any term or provision hereof is illegal
or invalid for any reason whatsoever, such illegality or invalidity shall not affect the validity of the remainder hereof.

 

5.08
Captions. The captions or headings in this Agreement are inserted for convenience and identification only and are not intended
to describe, interpret, define, or limit the scope, extent, or intent of this Agreement or any provisions hereof.

 

5.09
Applicable Law. The Buyer and Seller hereby agree this Agreement shall be governed by and construed and enforced under
and in accordance with the laws of the State of Nevada and all subject matter and in persona jurisdiction shall be the state courts
of Nevada and as such the Buyer and Seller irrevocably and unconditionally consent to submit to the exclusive jurisdiction of
the courts of the State of Nevada and of the United States of America located in Nevada for any actions, suits or proceedings
arising out of or relating to this Agreement and the Buyer and Seller agree not to commence any action, suite or proceedings relating
thereto except in such courts.

 

    	-13-

     

    

 

IN
WITNESS WHEREOF, the corporate parties hereto have caused this Agreement to be executed by their respective officers, hereunto
duly authorized, as of the date first above written.

 

	BUYER:	 	SELLER:
	Kibush
    Capital Corp.	 	Hancore
    Pty Ltd
	a
    Nevada Corporation	 	a
    shareholder of CBD Imports Pty Ltd

 

	By:		 	By:	
	Name:	WARREN
    SHEPPARD	 	Name:	WARREN
SHEPPARD
	Its:	DIRECTOR	 	Its:	DIRECTOR

 

    	-14-

     

    

 

Exhibit
A

 

SUITABILITY
LETTER

 

	TO:	Kibush
    Capital Corp.

 

I
make the following representations with the intent that they may be relied on by Kibush Capital Corp. (the “Company”),
in determining my suitability as a purchaser of securities of the Company (the “Shares”).

 

1.
I have had the opportunity to ask questions of, and receive answers and information, from the officers of the Company and I deemed
such information sufficient to make an investment decision on the Company.

 

2.
I have such knowledge and experience in business and financial matters that I am capable of evaluating the Company, its business
activities, and the risks and merits of this prospective investment, and i am not
utilizing a purchaser representative (as defined in regulation D) in connection with the evaluation of such risks and merits,
except the following:

 

3.
I shall provide a separate written statement from each purchaser representative on the Purchaser Representative Acknowledgment
form available from the Company in which is disclosed (i) the relationship of the purchaser representative with the Company, if
any, which has existed at any time during the previous two years, and compensation received or to be received as a result of such
relationship, and (ii) the education, experience, and knowledge in financial and business matters which enables the purchaser
representative to evaluate the relative merits and risks of an investment in the Company.

 

4.
The undersigned and the purchaser representatives listed above together have such knowledge and experience in financial and business
matters that they are capable of evaluating the Company and the proposed activities thereof and the merits and risks of this prospective
investment.

 

5.
I have adequate means of providing for my current needs and possible personal contingencies and have no need in the foreseeable
future for liquidity of an investment in the Company.

 

6.
Instructions: Complete either (a) or (b) below, as applicable:

 

(a)
FOR ACCREDITED INVESTORS. I confirm that I am an “accredited investor” as defined under rule 501 of regulation
D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), as checked below:

 

(i)
Any bank as defined in section 3(a)(2) of the Securities Act or any savings and loan association or other institution as defined
in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity; any broker or dealer registered
pursuant to section 15 of the Securities Exchange Act of 1934; any insurance company as defined in section 2(13) of the Securities
Act; any investment company registered under the Investment Company Act of 1940 or a business development company as defined in
section 2(a)(48) of that Act; any small business investment company licensed by the U. S. Small Business Administration under
section 301(c) or (d) of the Small Business Investment Act of 1958; any plan established and maintained by a state, its political
subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if
such plan has total assets in excess of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income
Security Act of 1974, if the investment decision is made by a plan fiduciary, as defined in section 3(21) of such Act, which is
either a bank, savings and loan association, insurance company, or registered investment adviser, or if the employee benefit plan
has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are
accredited investors;

 

	 	[  ]	Yes	[  ]	No	 

 

    	A-1

    	 

    

 

(ii)
Any private business development company as defined in section 302(a)(22) of the Investment Advisers Act of 1940;

 

	 	[X]	Yes	[  ]	No	 

 

(iii)
Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust,
or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

	 	[  ]	Yes	[  ]	No	 

 

(iv)
Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive
officer, or general partner of a general partner of that issuer;

 

	 	[  ]	Yes	[  ]	No	 

 

(v)
Any natural person whose individual net worth, or joint net worth with that person’s spouse, exclusive of residence, at
the time of his or her purchase exceeds $1,000,000;

 

	 	[  ]	Yes	[  ]	No	 

 

For
purposes of category (v), the term “net worth” means the excess of total assets over total liabilities.

 

(vi)
Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with
that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same
income level in the current year;

 

	 	[  ]	Yes	[  ]	No	 

 

In
determining income, the undersigned should add to his or her adjusted gross income any amounts attributable to tax exempt income
received, losses claimed as a limited partner in any limited partnership, deductions claimed for depletion, contributions to an
IRA or Keogh retirement plan, alimony payments, and any amount by which income from long-term capital gains has been reduced in
arriving at adjusted gross income.

 

(vii)
Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered,
whose purchase is directed by a sophisticated person as described in section 230.506(b)(2)(ii); and

 

	 	[  ]	Yes	[  ]	No	 

 

(viii)
Any entity in which all of the equity owners are accredited investors.

 

	 	[  ]	Yes	[  ]	No	 

 

    	A-2

    	 

    

 

(b)
FOR NONACCREDITED INVESTORS. I am not an accredited investor.

 

The
following information is being provided here in lieu of furnishing a personal financial statement.

 

(i)
My net worth excluding principal residence, furnishings, and automobiles is at least _____ times the total investment I intend
to make in the Company;

 

(ii)
My annual disposable income, after excluding all of my personal and family living expenses and other cash requirements for current
obligations, is such that the loss of my entire investment in the Company would not materially alter my standard of living;

 

	 	[  ]	Yes	[  ]	No	 

 

(iii)
Considering the foregoing and all other relevant factors in my financial and personal circumstances, I am able to bear the economic
risk of an investment in the Company.

 

	 	[  ]	Yes	[  ]	No	 

 

7.
I have previously been advised that I would have an opportunity to review all the pertinent facts concerning the Company, and
to obtain any additional information which I might request, to the extent possible or obtainable, without unreasonable effort
and expense, in order to verify the accuracy of the information provided me.

 

8.
I have personally communicated or been offered the opportunity to communicate with executive officers of the Company to discuss
the business and financial affairs of the Company, its products and activities, and its plans for the future. I acknowledge that
if I would like to further avail myself of the opportunity to ask additional questions of the Company, the Company will make arrangements
for such an opportunity on request.

 

9.
I have been advised that no accountant or attorney engaged by the Company is acting as my representative, accountant, or attorney.

 

    	A-3

    	 

    

 

10.
I will hold title to my interest as follows: 

 

	[  ]	Community
    Property	 	[  ]	Separate
    Property
	[  ]	Joint
    Tenants, with Right of	 	[  ]	Tenants
    in Common
	 	Survivorship	 	[  ]	Other
    (Single Person, Trust, Etc., Please Indicate.)
	 	 	 	 

 

DATED
this 26th day of June 2020.

 

	HANCORE
    PTY LTD	 	 
	 	 	 
	WARREN
    SHEPPARD DIRECTOR	 	 
	Name/Capacity	 	Name
    of Joint Subscriber, If Any
	 	 	 
		 	 
	Signature	 	Signature
	 	 	 
	7
    Sarah Crescent	 	 
	Street
    Address	 	Street
    Address
	 	 	 
	Templestowe
    VIC 3106	 	 
	City,
    State, and Zip Code	 	City,
    State, and Zip Code

 

    	A-4

    	 

    

 

INVESTMENT
LETTER

 

Kibush
Capital Corp.

 

	 	Re:	Purchase
    of Shares of Common Stock of Kibush Capital Corp.

 

Gentlemen:

 

In
connection with the acquisition by the undersigned of shares of Common Stock of Kibush Capital Corp. (the “Common Stock”),
the undersigned represents that the shares of Common Stock are being acquired without a view to, or for, resale in connection
with any distribution of such shares of Common Stock or any interest therein without registration or other compliance under the
Securities Act of 1933, as amended (the “Securities Act”), and that the undersigned has no direct or indirect participation
in any such undertaking or in the underwriting of such an undertaking.

 

The
undersigned understands that the shares of Common Stock have not been registered, but are being acquired by reason of a specific
exemption under the Securities Act as well as under certain state statutes for transactions by an issuer not involving any public
offering and that any disposition of the subject shares of Common Stock may, under certain circumstances, be inconsistent with
this exemption and may make the undersigned an “underwriter” within the meaning of the Securities Act. It is understood
that the definition of an “underwriter” focuses on the concept of “distribution” and that any subsequent
disposition of the subject shares of Common Stock can only be effected in transactions which are not considered distributions.
Generally, the term “distribution” is considered synonymous with “public offering” or any other offer
or sale involving general solicitation or general advertising. Under present law, in determining whether a distribution occurs
when securities are sold into the public market, under certain circumstances one must consider the availability of public information
regarding the issuer, a holding period for the securities sufficient to assure that the persons desiring to sell the securities
without registration first bear the economic risk of their investment, and a limitation on the number of securities which the
stockholder is permitted to sell and on the manner of sale, thereby reducing the potential impact of the sale on the trading markets.
These criteria are set forth specifically in rule 144 promulgated under the Securities Act.

 

    	 

    	 

    

 

Kibush
Capital Corp.

Page
Two

 

The
undersigned acknowledges that the shares of Common Stock must be held and may not be sold, transferred, or otherwise disposed
of for value unless it is subsequently registered under the Securities Act or an exemption from such registration is available;
the issuer is under no obligation to register the shares of Common Stock under the Securities Act or under section 12 of the Securities
Exchange Act of 1934, as amended, except as may be expressly agreed to by it in writing; if rule 144 is available, and no assurance
is given that it will be, initially only routine sales of such shares of Common Stock in limited amounts can be made in reliance
on rule 144 in accordance with the terms and conditions of that rule; the issuer is under no obligation to the undersigned to
make rule 144 available, except as may be expressly agreed to by it in writing; in the event rule 144 is not available, compliance
with regulation A or some other exemption may be required before the undersigned can sell, transfer, or otherwise dispose of such
shares of Common Stock without registration under the Securities Act; the issuer’s registrar and transfer agent will maintain
a stop transfer order against the registration of transfer of the shares of Common Stock will bear a legend in substantially the
following form so restricting the sale of such shares of Common Stock.

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND ARE “RESTRICTED SECURITIES” WITHIN THE MEANING OF RULE 144 PROMULGATED UNDER THE SECURITIES ACT.
THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD OR TRANSFERRED WITHOUT COMPLYING WITH RULE 144 IN THE ABSENCE
OF AN EFFECTIVE REGISTRATION OR OTHER COMPLIANCE UNDER THE SECURITIES ACT.

 

The
issuer may refuse to register transfer of the shares of Common Stock in the absence of compliance with rule 144 unless the undersigned
furnishes the issuer with a “no-action” or interpretative letter from the Securities and Exchange Commission or an
opinion of counsel reasonably acceptable to the issuer stating that the transfer is proper; further, unless such letter or opinion
states that the shares of Common Stock are free of any restrictions under the Securities Act, the issuer may refuse to transfer
the shares of Common Stock to any transferee who does not furnish in writing to the issuer the same representations and agree
to the same conditions with respect to such shares of Common Stock as are set forth herein. The issuer may also refuse to transfer
the shares of Common Stock if any circumstances are present reasonably indicating that the transferee’s representations
are not accurate.

 

	Name:
    	WARREN
    SHEPPARD	 
	 	 	 
	Its:
    	DIRECTOR	 
	 	 	 
	Date	June
    29th, 2020Exhibit
10.1

 

SECURITIES
PURCHASE AGREEMENT

 

THIS
SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of June 24, 2020, by and among Save Foods, Inc.,
a Delaware corporation (the “Company”) and ___________ (The “Investor”). This SPA is replacing
a CLA signed with the investor on _________.

 

WHEREAS,
the Company desires to issue and sell to the Investor, and the Investor desire to purchase from the Company, upon the terms and
conditions stated in this Agreement, for an aggregate purchase price of up to ________ (the “Purchase Price”),
______ units at a price of $1.09 (the “Units”), each Unit consists of (i) one share of Common Stock (the “Purchased
Shares”); and (ii) one warrant to purchase one share of Common Stock with an exercise price of $1.20 (the “Warrants”),
in the form attached hereto as Appendix A (collectively the “Warrants”, and together with the Purchased
Shares, the “Purchased Securities”), on the terms and conditions set forth in the Warrants; and

 

WHEREAS,
the Investor desire to purchase and the Company desires to issue and sell to the Investor the Securities pursuant to the terms
and conditions more fully set forth in this Agreement. The legend on the stocks will include the OID – January 6 2020.

 

NOW,
THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:

 

1.
PURCHASE AND SALE OF SECURITIES.

 

1.1
Sale and Issuance of Securities. Subject to the satisfaction of certain closing conditions set forth in Sections 4 and
5 hereof at the Closing (as defined below), the Company shall issue and sell to the Investor, and such Investor shall purchase,
severally and not jointly, from the Company , an aggregate of 49,541 Units at a purchase price of US$1.09 per each Unit.

 

1.2
Closing. The consummation of the transactions contemplated hereby, including the purchase and sale of the Purchased Securities
(the “Closing”) shall take place remotely via the exchange of documents and signatures, on June 24, 2020,
with the OID January 6 2020 or at such other time and place as the Company and the Investor mutually agree upon (such designated
time and place, the “Closing Date”). The Closing shall be subject to the conditions of Section 4 and 5 below,
which conditions shall be deemed to take place simultaneously and no transaction described in such sections shall be deemed to
have been completed or any document delivered until all such transactions have been completed and all such required documents
delivered.

 

1.3
Closing Deliverables.

 

(a)
At the Closing, the Company shall deliver to the Investor:

 

(i)
Book-entry confirmations representing respective Purchased Shares issued to each Investor at the Closing in the name of each of
such Investor.

 

(ii)
The Warrants issued to each Investor at the Closing in the name of each of such Investor; and

 

1.4
Purchase Price. Upon the execution of this Agreement, each Investor shall, severally and not jointly, transfer to the Company,
its respective portion of the Purchase Price by wire transfer of immediately available funds according to the wire instructions
attached hereto as Schedule 1.5.

 

2.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

The
Company hereby represents and warrants to each Investor that, the following representations are true, correct and complete as
of the date hereof and as of the Closing (as if made on the Closing Date); except, in each case, as to such representations and
warranties that address matters as of a particular date, which are true, correct and complete only as of such date. The Disclosure
Schedule shall be arranged in sections and subsections corresponding to the numbered and lettered sections and subsections contained
in this Section ‎2, and the information set forth in any one in any section or subsection of the Disclosure Schedule shall
apply to and qualify (a) the representation and warranty set forth in this Agreement to which it corresponds, and (b) whether
or not an explicit reference or cross-reference is made, each other representation and warranty set forth in this Agreement for
which it is reasonably apparent on its face that such information is relevant to such other section.

 

    	 

    	 

    

 

In
this Agreement, “Material Adverse Effect” means a material and adverse effect on the assets, properties, conditions
(financial or otherwise), operating results or business of the Company, as currently conducted.

 

2.1
Subsidiary. The Company wholly-owns Save Foods Ltd., an Israeli company (the “Subsidiary”), and as of
the date of the Agreement, the Subsidiary is the only subsidiary of the Company. The Company owns, directly , all of the capital
stock or other equity interests of the Subsidiary free and clear of any lien, charge, pledge, security interest, encumbrance,
right of first refusal, preemptive right or other restriction, and all of the issued and outstanding share capital of the Subsidiary
is validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.

 

2.2
Organization. The Company and the Subsidiary are each an entity duly incorporated or otherwise organized, validly existing
and in good standing (if applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization,
with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
Neither the Company nor the Subsidiary is in violation nor default of any of the provisions of its respective certificate of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiary is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in: (i) a Material Adverse Effect on the legality, validity
or enforceability of any Transaction Document, (ii) a Material Adverse Effect on the results of operations, assets, business,
prospects or condition (financial or otherwise) of the Company and the Subsidiary, taken as a whole, or (iii) a Material Adverse
Effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke,
limit or curtail such power and authority or qualification.

 

2.3
Capitalization.

 

(a)
The authorized share capital of the Company will be on or immediately following to the Closing, as set forth in the Company’s
Certificate of Incorporation (the “COI”), and such number of Common Stock as set forth in the Capitalization
Table are or shall be (immediately following the Closing) issued and outstanding, which shall reflect as of the date hereof, he
number of shares of Common Stock issued to Investor pursuant to the Agreement,

 

(b)
The issued and outstanding shares of the Company were duly and validly authorized and issued, fully paid and non-assessable, and
offered and issued in compliance with the provisions of the COI as in effect at the time of each such issuance and in compliance
with all applicable corporate and securities laws.

 

(c)
Immediately prior to the Closing, no shares, options, warrants, rights (including conversion, preemptive rights, rights of first
refusal or similar rights) or agreements for the purchase from the Company of any of its stock capital, or any securities convertible
into or exchangeable for stock of the Company shall be outstanding,

 

(d)
Immediately prior to the Closing, no option, security or other equity award convertible or exercisable into stock of the Company
shall contain a provision for acceleration of vesting (or lapse of a repurchase right) or other changes in the vesting provisions
or other terms of such option,

 

(e)
The Company has not declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or
series of its stock capital.

 

    	 

    	 

    

 

2.4
Authorization. All corporate action on the part of the Company, its directors and shareholders, necessary for the authorization,
execution and delivery of this Agreement and the other agreements, instruments or documents entered into in connection with this
Agreement and to which the Company is a party (collectively, the “Transaction Documents”) and for the performance
of all obligations of the Company under the Transaction Documents in accordance with their terms has been taken or will be taken
prior to the Closing. The Transaction Documents, when executed and delivered by the Company, and assuming the due authorization,
execution and delivery by the other parties hereto and thereto, constitute valid and binding obligations of the Company, enforceable
against the Company in accordance with their respective terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors’
rights generally, and (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other
equitable remedies.

 

2.5
Valid Issuance. The Purchased Securities being or that may be issued to the Investor hereunder, when issued, sold and delivered
in accordance with the terms of this Agreement for the consideration expressed herein, shall be duly and validly issued, fully
paid, and non-assessable, issued in compliance with all applicable state securities laws, and free and clear of liens, pledges,
charges, encumbrances or other restrictions on transfer of any kind (including, without limitation, preemptive rights), other
than restrictions on transfer under this Agreement, the COI, the Company’s currently effective Bylaws (the “Bylaws”)
and under applicable securities laws and other than liens or encumbrances created by or imposed on each Investor as to itself.
The rights, privileges and preferences of the Purchased Securities are as stated in the COI and Bylaws, as may be amended from
time to time in accordance with its terms.

 

2.6
No Conflict; Consents. The execution, delivery and performance by the Company of this Agreement and the other Transaction
Documents to which it is a party, the issuance and sale of the Purchased Securities and the consummation by it of the transactions
contemplated hereby and thereby do not and will not: (i) conflict with or violate any provision of the COI or Bylaws or other
organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time
or both would become a default) under, result in the creation of any lien, charge, pledge, security interest, encumbrance, right
of first refusal, preemptive right or other restriction, upon any of the properties or assets of the Company, or give to others
any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company
is a party or by which any property or asset of the Company is bound or affected, or (iii) subject to the Required Approvals,
conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction
of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company is bound or affected; except in the case of each of clauses (ii) and (iii), such
as could not have or reasonably be expected to result in a Material Adverse Effect.

 

2.7
SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents
required to be filed by the Company under the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) since the Company’s registration statement on Form 10 was determined effective (collectively, the “SEC
Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules
and regulations of the U.S. Securities and Exchange Commission (the “Commission”) with respect thereto as in
effect at the time of filing. Such financial statements have been prepared in accordance with Generally Accepted Accounting Principles
in the U.S. (“US GAAP”), except as may be otherwise specified in such financial statements or the notes thereto
and except that unaudited financial statements may not contain all footnotes required by US GAAP, and fairly present in all material
respects the financial position of the Company as of and for the dates thereof and the results of operations and cash flows for
the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

    	 

    	 

    

 

2.8
Continued Quotation. The Company is, and has no reason to believe that it will not in the foreseeable future continue to
be, in compliance with all such quotation and maintenance requirements of the “Pink Sheets” published and maintained
by OTC Markets Group, Inc., and shall make commercial best efforts to maintain such compliance.

 

2.9
Financial Statements; No Undisclosed Liabilities.

 

(a)
The Company has no liabilities or obligations, contingent or otherwise, other than (i) liabilities incurred in the ordinary course
of business, which, individually and in the aggregate, do not exceed US$200,000; (ii) obligations under contracts and commitments
incurred in the ordinary course of business including debt of the Subsidiary to the parent company of the Company in the principal
amount of US$500,000; (iii) liabilities and obligations of a type or nature not required under GAAP to be reflected in its financial
statements, which, individually and in the aggregate do not exceed US$100,000;

 

(b)
The Company is not a guarantor or indemnitor of any debt or obligation of another, nor has the Company given any loan, security
or otherwise agreed to become liable for any obligation of any person. No person has given any guarantee of, or security for,
any obligation of the Company. The Company did not extend any loans or advances to any person, other than advances for expenses
to its employees in the ordinary course of business.

 

2.10
Assets and Properties. Both the Company and the Subsidiary have good and marketable title to all of the tangible or personal
properties and assets owned by the Company and the Subsidiary, which are material to the business of the Company or the Subsidiary
as currently conducted, and such properties and assets are free and clear of all mortgages, deeds of trust, liens, pledges, charges,
security interests, conditional sale agreement, loans and encumbrances, except for statutory liens for the payment of current
taxes that are not yet delinquent and encumbrances and liens that arise in the ordinary course of business and do not materially
impair the Company’s or the Subsidiary’s ownership or use of such property or assets. With respect to the tangible
property and assets it leases, the Company and the Subsidiary are in compliance in all material respects with such leases and,
to its knowledge, holds a valid leasehold or license interest free of any liens, pledges, charges, security interest, claims or
encumbrances, other than those of the lessors of such property or assets. The Company and the Subsidiary do not own any real property.

 

2.11
Intellectual Property. The Company and the Subsidiary have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property
rights and similar rights for use in connection with their respective businesses and which the failure to so have could have a
Material Adverse Effect (collectively, the “Intellectual Property Rights”). Neither the Company nor the Subsidiary
have received a notice (written or otherwise) that any of, the material Intellectual Property Rights has expired, terminated or
been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither
the Company nor the Subsidiary have received, since Jan 1, 2019, a written notice of a claim or otherwise has any knowledge that
the Intellectual Property Rights violate or infringe (and will not infringe) upon the rights of any Person, except as could not
have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property
Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The
Company and the Subsidiary have taken reasonable security measures to protect the secrecy, confidentiality and value of all of
their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it or the Subsidiary from having
valid license rights or clear title to the Intellectual Property Rights. The Company has no knowledge that either it or the Subsidiary
lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct
its business. For purposes of this Section, “knowledge”, including the phrase “to the Company’s knowledge”
(or similar phrases), when used in this Section 2.11 (Intellectual Property) shall mean the actual knowledge of the Company,
without conducting any patent search, freedom to operate, infringement, or any similar search.

 

    	 

    	 

    

 

2.12
Labor Matters.

 

(a)
The Company and the Subsidiary have complied, in all material respects, with all applicable employment laws, policies, procedures
and agreements relating to employment, and terms and conditions of employment. The Company and the Subsidiary have paid in full
to all of its respective employees and consultants all wages, salaries, commissions, bonuses, benefits and other compensation
due and payable to such employees or consultants on or prior to the date of this Agreement. The Company and the Subsidiary have
complied in all material respects with the applicable laws relating to the proper withholding and remittance to the proper tax
and other authorities of all sums required to be withheld from employees or persons deemed to be employees under applicable laws.
To the Company’s knowledge, all persons classified by the Company or the Subsidiary as consultants or contractors thereof
are correctly classified as such and not as employees for any purpose. The Company’s and the Subsidiary’s liability
for any obligations to pay any amount of severance payment, pension, accrued vacation, and other social benefits and contributions,
under applicable law or contract, or any other payment of substantially the same nature, is fully funded by deposit of funds in
severance funds, pension funds, managers insurance policies or provident funds (and if not required to be so funded) adequate
provisions have been made in the Company’s Financial Statements.

 

(b)
Neither the Company nor the Subsidiary is a party to, bound by or subject to, and no employee of the Company or the Subsidiary
benefits from, any collective bargaining agreement, collective labor agreement, extension orders (tzavei harchava) (other
than extension orders that apply to all employees in Israel generally), or other contract or arrangement with a labor union, trade
union or other organization or body, to provide benefits or working conditions beyond the minimum benefits and working conditions
required by applicable law. No labor union has requested or has sought to represent any of the employees, representatives or agents
of the Company or the Subsidiary, nor is the Company or the Subsidiary aware of any labor organization activity involving its
employees. There is no strike or other labor dispute involving the Company or the Subsidiary pending or, to the Company’s
knowledge, threatened.

 

2.13
Taxes. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in
a Material Adverse Effect, the Company and the Subsidiary each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is
subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the
payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. Except
as disclosed in SEC Reports, there are no unpaid taxes in any material amount claimed to be due by the taxing authority of any
jurisdiction, and neither the officers of the Company nor the Subsidiary know of no basis for any such claim.

 

2.14
Governmental Grants. Neither the Company nor the Subsidiary have applied, obtained or received any grant, loan, incentives,
benefits (including tax benefits), subsidies or other assistance from any governmental or regulatory authority or any agency,
or any international or bilateral fund, institute or organization or public entities or authorities.

 

2.15
Litigation. There is no claim, action, suit, proceeding, arbitration, complaint, charge or, to the Company’s knowledge,
investigation pending, or, to the Company’s knowledge, currently threatened in writing against the Company or the Subsidiary,
any of its properties, or any officer, director or employee of the Company or the Subsidiary, including, without limitation, arising
out of their employment or board relationship with the Company or the Subsidiary or in their capacity as such, or that questions
the validity of the Transaction Documents or the right of the Company to enter into them, or to consummate the transactions contemplated
by the Transaction Documents.

 

2.16
Insurance. The Company and the Subsidiary are covered by insurance with respect to its properties and business.

 

2.17
Disclosure. No representation or warranty of the Company contained in this Agreement, as qualified by the Disclosure Schedule,
and no certificate furnished or to be furnished to Investor at the Closing contains any untrue statement of a material fact or,
to the Company’s knowledge, omits to state a material fact necessary in order to make the statements contained herein or
therein not misleading in light of the circumstances under which they were made.

 

    	 

    	 

    

 

3.
REPRESENTATIONS AND WARRANTIES OF THE INVESTOR.

 

Each
of the Investor, severally and not jointly, hereby represents and warrants, with respect to itself only, that the following representations
are true, correct and complete as of the date hereof and as of the Closing (as if made on the Closing Date); except, in each case,
as to such representations and warranties that address matters as of a particular date, which are given only as of such date:

 

3.1
Authorization; Organization. The Investor is duly organized, validly existing and, if applicable, in good standing under
the laws of the jurisdiction in which it has been incorporated and has full power and authority to enter into the Transaction
Documents. The Transaction Documents to which the Investor is a party, when executed and delivered by the Investor, and assuming
the due authorization, execution and delivery by the other parties hereto and thereto, constitute valid and binding obligations
of the Investor, enforceable against the Investor in accordance with their respective terms, except (i) as limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or
affecting the enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies, and (iii) to the extent the indemnification provisions contained
herein, as may be limited by applicable securities laws.

 

3.2
No Conflict; Consents. The execution, delivery and performance by the Investor of the Transaction Documents to which it
is a party and the consummation of the transactions contemplated by such Transaction Documents do not and will not (a) result
in any conflict with, or a breach or violation, with or without the passage of time and giving of notice, of any of the terms,
conditions or provisions of, or give rise to rights to others (including rights of termination, cancellation or acceleration)
under: (i) the governing documents of the Investor; (ii) any judgment, injunction, order, writ, decree or ruling of any court
or governmental authority, domestic or foreign, to which the Investor is subject; (iii) any material contract or agreement, lease,
license or commitment to which the Investor is a party or by which it is bound; (iv) any applicable law; or (b) require the consent,
approval or authorization of, registration, qualification or filing with, or notice to any person or any federal, state, local
or foreign governmental authority or regulatory authority or agency, on the part of the Investor, which has not heretofore been
obtained or made or will be obtained or made prior to Closing.

 

3.3
Purchase Entirely for Own Account. The Purchased Securities will be acquired for investment for the Investor’s own
account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and the Investor has
no present intention of selling, granting any participation in, or otherwise distributing the same. The Investor does not presently
have any contract, undertaking, agreement or arrangement to sell, transfer or grant participation rights to any person with respect
to any of the Purchased Securities. The Investor has not been formed for the specific purpose of acquiring the Purchased Securities.

 

3.4
Disclosure of Information. The Investor has had an opportunity to discuss the Company’s business, operations, properties,
prospects, technology, plans, management, financial affairs and the terms and conditions of the offering of the Purchased Securities
with the Company’s management and has had an opportunity to review the Company’s facilities. The foregoing, however,
does not limit, modify or qualify the representations and warranties of the Company in Section ‎2 of this Agreement or the
right of the Investor to rely thereon. The Investor acknowledges that any projections provided (if any) by the Company are uncertain
in nature, and that some or all of the assumptions underlying such projections may not materialize or will vary significantly
from actual results.

 

3.5
Investment Experience; Accredited Investor; Non-U.S. Person. The Investor is an investor in securities of companies in
the development stage and acknowledges that it is able to fend for itself, can bear the economic risk of its investment, and has
such knowledge and experience in financial or business matters that it is capable of evaluating and understanding the merits and
risks of the investment in the Purchased Securities. The Investor is either (i) an accredited investor as defined in Rule 501(a)
of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), or (ii) a
Non U.S. Person as defined under Regulation S promulgated under the Securities Act. To the extent that the Investor is a non U.S.
Person, such Investor (x) is not acquiring Purchased Securities for the account or benefit of any U.S. Person, (y) is not, at
the time of execution of this Agreement, and will not be, at the time of the Closing, in the United States and (z) is not a “distributor”
(as defined in Regulation S promulgated under the Securities Act).

 

    	 

    	 

    

 

3.6
Restricted Securities. The Purchased Securities have not been and will not be registered under the Securities Act or any
state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state
securities laws or unless an exemption from such registration requirements is available. Investor is aware that, except as set
forth herein, the Company is under no obligation to effect any such registration or to file for or comply with any exemption from
registration. The sale and issuance of the Purchased Securities have not been registered under the Securities Act by reason of
a specific exemption from registration which depends upon, among other things, the accuracy of the Investor’s representations
as expressed herein.

 

3.7
Legends. The Purchased Securities, and (if applicable) any securities issued in respect of or exchange for the foregoing
may be notated with the following or a similar legend as well as other legends as may be required by applicable securities laws:
“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT
AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO TRANSFER OF SUCH SHARES MAY BE EFFECTED WITHOUT
AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION
IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.”

 

3.8
Exculpation among Investor. The Investor is not relying upon any other Investor in making its investment or decision to
invest in the Company. Neither of the other Investor nor the respective controlling persons, officers, directors, partners, agents,
employees or legal or other advisors of any such other Investor shall be liable to the Investor for any action heretofore taken
or omitted to be taken by any of them in connection with the purchase of the Purchased Securities.

 

4.
CONDITIONS OF INVESTOR’ OBLIGATIONS AT CLOSING.

 

The
obligations of each Investor to purchase the Purchased Securities at the Closing are subject to the fulfillment on or before the
Closing of each of the following conditions, unless otherwise waived in writing by the Majority Investor:

 

4.1
Representations and Warranties. The representations and warranties of the Company in Section 2 of this Agreement shall
have been true in all respects on and as if made as of the Closing.

 

4.2
Performance. The Company shall have performed and complied, in all respects, with all agreements, obligations and conditions
contained in this Agreement that are required to be performed or complied with by it on or before the Closing.

 

4.3
Delivery of Documents. All of the documents to be delivered by the Company pursuant to Section 1.5, shall have been in
a form as attached to this Agreement, or, if not attached, in a form and substance satisfactory to the Investor and shall have
been delivered to the Investor.

 

5.
CONDITIONS OF THE COMPANY’S OBLIGATIONS AT CLOSING.

 

The
obligations of the Company to the Investor under this Agreement are subject to the fulfillment on or before the Closing, of each
of the following conditions, unless otherwise waived in writing by the Company:

 

5.1
Representations and Warranties. The representations and warranties contained in Section ‎3 shall have been true in
all respects on and as if made as of the Closing.

 

5.2
Performance. Each of the Investor shall have performed and complied, in all respects, with all agreements, obligations
and conditions contained in this Agreement that are required to be performed or complied with by it on or before the Closing.

 

6.
AFFIRMATIVE COVENANTS BY THE COMPANY.

 

6.1
Use of Proceeds. The Company will use the Purchase Price for general working capital purposes.

 

6.2
Conduct of the Business between Signing and Closing. Except as otherwise expressly provided by this Agreement or with the
prior written consent of each of the Investor individually (which consent shall not be unreasonably withheld or delayed), the
Company shall (i) conduct its business in the ordinary course of business, consistent with prior practice; (ii) comply with legal
requirements applicable to the operation of its business and pay applicable taxes as due; (iii) maintain its books, accounts and
records in the ordinary course of business; and (iv) not take any other action that would result in a breach of any of the representations,
warranties or covenants made by the Company in this Agreement or that would adversely affect its ability to consummate the transactions
contemplated by this Agreement.

 

    	 

    	 

    

 

7.
INDEMNIFICATION.

 

7.1
Effectiveness; Survival.

 

(a)
Each Investor has the right to fully rely upon all representations, warranties and covenants of the Company, for which the Company
shall be held responsible (the “Indemnitor”) contained in or made pursuant to this Agreement and in the schedules
attached hereto. Unless otherwise set forth in this Agreement, the representations and warranties of the Company contained in
or made pursuant to this Agreement shall in no way be affected by any investigation or knowledge of the subject matter thereof
made by or on behalf of any Investor.

 

(b)
The representations and warranties of the Company contained in or made pursuant to this Agreement shall survive the execution
and delivery of this Agreement and the Closing, until (1) in case of Section 2.11 (Intellectual Property), until the 30th
months anniversary of the Closing Date; (2) in case of Sections 2.2 (Organization), 2.4 (Authorization) and
2.6 (No Conflict; Consents), until the expiration of the applicable statute of limitation period; and (3) other than as
set forth in clause (1) above, the 24th months anniversary of the Closing Date; in each case, with respect to any theretofore
un-asserted claims as set forth in clause (d) below;

 

(c)
In respect to Section 7.1(b) above, no limitation shall apply to breach of any representation or warranty which constitutes fraud
or willful misrepresentation by the Company (“Fraud”). The applicable survival period shall be referred to,
as applicable, as the “Claims Period”.

 

(d)
Except for Fraud, the Company shall have any liability with respect to any breach of representation and warranty, unless a claim
is made hereunder prior to the expiration of the Claims Period for such representation and warranty, in which case such representation
and warranty shall survive as to that claim until the claim has been finally resolved.

 

(e)
It is the intention of the parties hereto that the Claims Periods supersede any statute of limitations applicable to the representations
and warranties, and this Section ‎7.1 constitutes a separate written legally binding agreement among the parties hereto
in accordance with the provisions of Section 19 of the Israeli Limitation Law, 1958.

 

7.2
Indemnification.

 

(a)
Indemnifiable Losses. The Indemnitor shall indemnify each Investor (including its shareholders, limited and general partners
directors and officers) (each, an “Indemnitee”) against, and hold each Indemnitee harmless from all claims,
actions, suits, settlements, damages, expenses (including, reasonable legal costs and expenses), losses, or costs sustained or
incurred by such Indemnitees (collectively, “Losses”) resulting from, or arising out of, a breach or misrepresentations
of any the Indemnitor’s representations, warranties or covenants made in this Agreement, subject to the limitations in this
Section ‎7.

 

(b)
Limitations. The Indemnitee’s right for indemnification hereunder is subject to the following conditions and limitations,
notwithstanding anything to the contrary in this Agreement, but in to any other limitation or condition contained herein; provided,
however, no limitation shall apply to Fraud:

 

(i)
Other than in respect of the Fundamental Representations, no Indemnitor shall be liable for any Loss, unless and until the aggregate
of Losses equal or exceeds US$100,000, in which case indemnification shall be made from the first dollar amount.

 

(ii)
The Indemnitor’s liability shall be limited with respect to each Investor to the respective portion of Purchase Price of
such Investor at the Closing and each Indemnitee shall be entitled to receive a pro rata share of the indemnifiable Loss, based
on the respective portion of such Investor of the Purchase Price as of the Closing.

 

    	 

    	 

    

 

(c)
Claims Notice; Third Party Claims. In the event that an Indemnitee wishes to assert a claim for indemnification hereunder
it shall give the Indemnitor a prompt written notice thereof (a “Claims Notice”), which shall describe in reasonable
detail the facts and circumstances upon which the asserted claim for indemnification is based and thereafter keep the Indemnitor
informed, in all material respects, with respect thereto. In the event that such Claims Notice results from a third party claim
against the Indemnitee, such Indemnitee shall promptly upon becoming aware of the commencement of proceedings by such third party
provide the Indemnitor with the Claims Notice and the Indemnitor shall have the right to assume the defense thereof (at Indemnitor’s
expense) with counsel mutually satisfactory to the parties; provided, however, that the Indemnitees shall have the right
to retain their own counsel, at the reasonable expense of the Indemnitor, and within the indemnification limitations herein, if
representation of all parties by the counsel retained by the Indemnitor would be inappropriate due to actual or potential differing
interests between the parties in such proceeding. Failure of the Indemnitees to give prompt notice or to keep it informed, as
provided herein, shall not relieve the Indemnitor of any of its obligations hereunder, except to the extent that the Indemnitor
is actually and materially prejudiced by such failure. The Indemnitor shall not be liable nor shall it be required to indemnify
or hold harmless the Indemnitee in connection with any settlement effected without its consent in writing, which shall not be
unreasonably withheld or delayed.

 

(d)
Sole Remedy. The indemnification provided by the Indemnitor hereunder and the enforcement of such indemnification shall
be the exclusive remedy available to the Indemnitees under this Agreement, other than for Fraud; provided that this provision
does not limit the right to seek specific performance, a restraining order or injunctive relief with respect to any provision
of this Agreement.

 

8.
MISCELLANEOUS.

 

8.1
Further Assurances. Each of the parties hereto shall perform such further acts and execute such further documents as may
reasonably be necessary to carry out and give full effect to the provisions of this Agreement and the intentions of the parties
as reflected thereby.

 

8.2
Entire Agreement. This Agreement (including the exhibits and schedules hereto) and the other Transaction Documents constitute
the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and supersede all
prior agreements and understandings, both written and oral, among any of the parties hereto, with respect to the subject matter
hereof (with no concession being made as to the existence of any such prior agreements or understandings).

 

8.3
Amendment; Waiver. Except as explicitly set forth herein, any term of this Agreement may be amended only with the written
consent of both the Company and the Majority Investor, provided that any amendment amending an Investor’s respective portion
of the Purchase Price to be invested at the Closing, or any amendment that has a disproportionate and adverse effect on specific
Investor(s) (as compared to other Investor), shall require also such specific Investor’s prior written consent. The observance
of any term hereof may be waived (either prospectively or retroactively and either generally or in a particular instance) only
by the prior written consent of the party against which enforcement of such waiver shall be sought (and in case enforcement will
be sought against the Investor, of the Majority Investor). Any amendment or waiver effected in accordance with this Section ‎8.3
shall be binding upon the Investor and each transferee of the Purchased Securities, each future holder of all such securities
and the Company.

 

8.4
Assignment; Successors and Assigns. None of the rights, privileges or obligations set forth in, arising under, or created
by this Agreement may be assigned or transferred by an Investor, without the prior written consent of the Company. Nothing in
this Agreement, express or implied, is intended to confer upon any party other than the parties hereto any rights, remedies, obligations,
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

8.5
Governing Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with to the laws of the State
of Israel, disregarding its conflict of laws rules. Any dispute arising under or in relation to this Agreement shall be resolved
exclusively in the competent court located in Tel Aviv-Jaffa, Israel and each of the parties hereby irrevocably submits to the
exclusive jurisdiction of such court. Each of the parties hereto (i) consents to submit itself to the exclusive jurisdiction of
the abovementioned courts in the event any dispute arises out of this Agreement or the transactions contemplated by this Agreement,
(ii) agrees that it shall not attempt to deny or defeat such jurisdiction by motion or other request for leave from the abovementioned
court, (iii) agrees that it shall not bring any action relating to this Agreement or the transactions contemplated by this Agreement
in any court other than the abovementioned court, and (iv) irrevocably consents to service of process in the manner provided by
Section ‎8.6 or as otherwise provided by applicable law.

 

    	 

    	 

    

 

8.6
Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be
deemed effectively given upon the earlier of actual receipt, or (i) when delivered, if sent by personal delivery to the party
to be notified, (ii) when sent, if sent by electronic mail or facsimile (with electronic conformation of delivery) on a business
day and during normal business hours of the recipient, and otherwise on the first business day in the place of recipient, (iii)
five (5) business days after having been sent, if sent by registered or certified mail, return receipt requested, postage prepaid,
or (iv) one (1) business day after deposit with an internationally recognized overnight courier, freight prepaid, specifying next
business day delivery, with written confirmation of receipt. All communications shall be sent to the respective parties at their
address or contact details as set forth below, or to such address or contact details as subsequently modified by written notice
given in accordance with this Section 8.6 or, in the case of the Investor, as used for purposes of sending shareholders’
notices by the Company.

 

	If
    to the Company:	Habarzel 7, Tel Aviv, Israel 6971011 
	 	Attention:	Dan
    Sztybel
	 	Telephone:	+972-72-2116144
	 	E-mail:	dan@savefoods.co
	 	 	 
	 	with a mandatory copy to (which shall not constitute a notice):
	 	 	 
	 	Meitar Law Offices

16 Abba Hillel St., Ramat-Gan, Israel

	 	Attention:	Dr.
    Shachar Hadar, Adv.
	 	Telephone:	+972-3-6103961
	 	E-mail:	shacharh@meitar.com
	 	 	 
	If
    to the Investor:	as set forth on the signature page hereto/Exhibit A

 

8.7
Delays or Omissions. Except as expressly provided herein, no delay or omission to exercise any right, power or remedy accruing
to any party to this Agreement upon any breach or default of any other party under this Agreement, shall impair any such right,
power or remedy of such non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence
therein, or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed
a waiver of any other breach or default therefore or thereafter occurring. Any waiver, permit, consent or approval of any kind
or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of
any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set
forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement,
shall be cumulative and not alternative.

 

8.8
Interpretation. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered
in construing or interpreting this Agreement. The words “include”, “includes” and “including”
shall be deemed to be followed by the phrase “without limitation”. Unless the context requires otherwise, the words
“herein”, “hereof” and “hereunder”, and words of similar import, shall be construed to refer
to this Agreement in its entirety, and not to any particular provision hereof, and all references herein to Sections shall be
construed to refer to Sections to this Agreement. Reference to “governmental authorities” (or similar terms) shall
include any: (a) nation, principality, state, commonwealth, territory, county, municipality, district or other jurisdiction of
any nature, (b) federal, state, local, municipal, foreign or other government, (c) governmental, quasi-governmental or regulatory
body of any nature, including any governmental division, subdivision, department, agency, bureau, branch, office, commission,
council, board, instrumentality, organization, unit, or body, or (d) court, public or private arbitrator or other public tribunal.
Reference to a “person” shall mean any individual, corporation, partnership, limited liability company, firm, joint
venture, association, joint-stock company, trust, estate, unincorporated organization, governmental authority or other entity,
including, any party to this Agreement. Any reference to a “day” or a number of days (without explicit reference to
“business days”) shall be interpreted as a reference to a calendar day or number of calendar days, and if any action
is to be taken or given on or by a particular calendar day, and such calendar day is not a business day, then such action may
be deferred until the first business day thereafter (where “business day” shall mean any day on which banking institutions
in Tel-Aviv-Jaffa, Israel are generally open to the public for conducting business and are not required by law to close).

 

8.9
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision
shall be excluded from this Agreement and the balance of the Agreement shall be enforceable in accordance with its terms and interpreted
so as to give effect, to the fullest extent consistent with and permitted by applicable law, to the meaning and intention of the
excluded provision.

 

8.10
Counterparts. This Agreement and any Transaction Document may be executed in one or more counterparts, all of which together
shall constitute one and the same instrument, binding and enforceable against the parties so executing the same; it being understood
that all parties need not sign the same counterpart. Counterparts may also be delivered by facsimile or email transmission (in
pdf format or the like, or signed with docusign, e-sign or any similar form of signature by electronic means) and any counterpart
so delivered shall be sufficient to bind the parties to this Agreement or any other Transaction Document, as an original.

 

-
Signature Pages Follow -

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this SECURITIES PURCHASE AGREEMENT to be executed as of the date first written above.

 

	 	COMPANY:
	 	 
	 	SAVE
    FOODS, INC.
	 	 	 
	 	By:	    
	 	Name:	Dan
    Sztybel
	 	Title:	Chief
    Executive Officer

 

[Company
Signature Page to Securities Purchase Agreement]

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this SECURITIES PURCHASE AGREEMENT as of the date first written above.

 

INVESTOR:

 

Signature:
__________________________

 

Name:

Title:

 

Investment
Amount:

 

[Investor
Signature Page to Securities Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]